RTT105 Antibody

What is RTT105 and why would researchers need antibodies against it?

RTT105 is a protein in Saccharomyces cerevisiae that functions as a molecular chaperone for Replication Protein A (RPA), an essential single-stranded DNA (ssDNA) binding protein. RTT105 plays a dual role: it regulates RPA nuclear localization and facilitates RPA loading onto ssDNA at replication forks . Antibodies against RTT105 are valuable research tools for detecting, isolating, and characterizing this protein and its interactions, particularly in studies examining DNA replication, repair mechanisms, and genome stability maintenance.

What methods can be used to validate the specificity of RTT105 antibodies?

When validating RTT105 antibodies, researchers should employ multiple approaches:

• Western blot analysis using wild-type and rtt105Δ cell extracts: Compare detection in wild-type versus knockout samples. The absence of signal in rtt105Δ extracts confirms specificity.

• Immunoprecipitation followed by mass spectrometry: This approach helps identify whether the antibody pulls down RTT105 and its known interacting partners (RPA subunits and Kap95) .

• Recombinant protein detection: Test antibody against purified recombinant RTT105 protein (such as MBP-tagged RTT105) at various concentrations .

• Cell cycle-specific detection: Since the RTT105-RPA interaction peaks during S phase and diminishes at G2/M phase, validate antibody detection across synchronized cell populations .

What sample preparation techniques are optimal for RTT105 detection in yeast?

For optimal RTT105 detection in yeast samples:

• Cell lysis buffer composition: Use TMG-140 buffer (10 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 10% v/v glycerol, 140 mM NaCl, 0.1 mM EDTA, 0.5% Tween20, 1 mM DTT with complete protease inhibitors) .

• DNA digestion: Treat lysates with benzonase for 30 minutes at 4°C to digest DNA that might interfere with antibody binding .

• Clearing lysates: Centrifuge samples to remove cell debris before immunoprecipitation or western blotting.

• Protein separation: Use gradient gels for optimal separation of RTT105 (~25 kDa) from its interaction partners .

How can RTT105 antibodies be used to study its interaction with RPA?

RTT105 antibodies can be employed in multiple experimental approaches to study its interaction with RPA:

• Co-immunoprecipitation (Co-IP): Pull down RTT105 using specific antibodies and detect associated RPA subunits by western blotting. This technique has successfully demonstrated that the RTT105-RPA interaction is cell cycle-dependent, peaking during S phase .

• Reciprocal immunoprecipitation: Perform IP of TAP-tagged Rfa1 (RPA subunit) and detect RTT105 in the associated complex using RTT105 antibodies .

• Fluorescence resonance energy transfer (FRET): Combined with fluorescently labeled proteins, antibodies can help validate FRET results showing RTT105-RPA proximity in native contexts .

• Chromatin immunoprecipitation (ChIP): Use RTT105 antibodies to investigate its localization at replication forks in relation to RPA binding sites.

• Immunofluorescence microscopy: Employ RTT105 antibodies to visualize its co-localization with RPA in the nucleus and at nuclear periphery under different cellular conditions .

What controls should be included when using RTT105 antibodies in research?

When using RTT105 antibodies, include these essential controls:

• Genetic controls: Include samples from rtt105Δ strains as negative controls in all experiments .

• Isotype controls: Use matched isotype antibodies to control for non-specific binding.

• Competitive binding controls: Pre-incubate antibodies with recombinant RTT105 protein to demonstrate binding specificity.

• Cell cycle controls: Since RTT105-RPA interaction varies throughout the cell cycle, include synchronized cells at different cell cycle stages .

• RPA mutant samples: Include samples from cells expressing RPA DNA binding mutants (zm1, zm2, t33) which maintain RTT105 interaction but have altered DNA binding properties .

How can researchers use RTT105 antibodies to study its role during replication stress?

RTT105 antibodies can provide valuable insights into replication stress responses:

• ChIP-seq analysis: Use RTT105 antibodies in ChIP-seq experiments to map its genome-wide localization at normal and hydroxyurea (HU)-stalled replication forks.

• Immunofluorescence under stress conditions: Compare RTT105 localization patterns in normal conditions versus HU treatment or other replication stressors .

• Co-immunoprecipitation during stress: Isolate RTT105-associated protein complexes during replication stress to identify stress-specific interaction partners.

• Proximity ligation assays: Combine RTT105 and RPA antibodies to quantify their interaction frequency under normal and stressed conditions.

• Western blotting time-course: Monitor RTT105 protein levels and post-translational modifications during recovery from replication stress.

How can RTT105 antibodies be used in single-molecule studies?

For single-molecule investigations of RTT105 function:

• Antibody-based protein detection: RTT105 antibodies can be used to verify the purity and identity of recombinant proteins prior to single-molecule experiments.

• Surface immobilization: Immobilize RTT105 antibodies on microscope slides to capture and study individual RTT105 molecules or complexes.

• Super-resolution microscopy: Use fluorescently labeled RTT105 antibodies in techniques like STORM or PALM to visualize RTT105 localization at nanometer resolution.

• Validation of fluorescent tags: Antibodies can confirm that fluorescently tagged RTT105 constructs used in single-molecule FRET studies retain normal binding properties and function .

Research has shown that RTT105 affects the binding mode of RPA to ssDNA in single-molecule studies, yet does not remain in the final RPA-ssDNA complex . Antibodies specific to different domains of RTT105 can help track its association and dissociation kinetics.

What approaches can resolve contradictory data in RTT105-RPA interaction studies?

When facing contradictory results in RTT105-RPA interaction studies:

• Domain-specific antibodies: Develop antibodies targeting specific regions of RTT105 to determine which domains mediate different aspects of RPA interaction. Studies have identified that deletion of different 50-amino acid intervals of RTT105 (Δ2–52, Δ53–103, Δ104–154, and Δ155–208) affects RPA binding differently .

• Antibody epitope mapping: Use epitope mapping to ensure antibodies don't interfere with RTT105-RPA interaction surfaces.

• Combined techniques approach: Validate findings using multiple techniques (FRET, Co-IP, ChIP, etc.) as contradictory results may stem from methodological limitations.

• In vitro versus in vivo discrepancies: Some studies showed no difference in RPA-ssDNA binding affinity with RTT105 in vitro, while in vivo studies demonstrated defects in RPA loading at replication forks in rtt105Δ cells . Using antibodies in both contexts can help reconcile these differences.

• Temporal resolution studies: Use antibodies to track RTT105-RPA interactions with high temporal resolution, as some contradictions may result from examining different time points in dynamic processes.

What methodology should be used to detect RTT105 post-translational modifications?

To study RTT105 post-translational modifications:

• Phospho-specific antibodies: Develop antibodies that specifically recognize phosphorylated forms of RTT105 to study its regulation during cell cycle or stress conditions.

• Two-dimensional gel electrophoresis: Combine with RTT105 antibodies in western blotting to detect charge variants resulting from modifications.

• Immunoprecipitation followed by mass spectrometry: Use RTT105 antibodies to pull down the protein and analyze modifications by mass spectrometry.

• Lambda phosphatase treatment: Compare antibody detection of RTT105 before and after phosphatase treatment to identify phosphorylation-dependent epitopes.

RTT105 has two non-conserved native cysteine residues (Cys12 and Cys13) that can be modified . Specific antibodies detecting modified versus unmodified forms could help understand their functional significance.

What is the optimal protocol for RTT105 immunoprecipitation?

For effective RTT105 immunoprecipitation:

• Lysis conditions: Lyse yeast cells in TMG-140 buffer (10 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 10% v/v glycerol, 140 mM NaCl, 0.1 mM EDTA, 0.5% Tween20, 1 mM DTT with protease inhibitors) using bead beating .

• DNA digestion: Treat lysates with benzonase for 30 minutes at 4°C to eliminate DNA-mediated interactions .

• Antibody binding: Incubate cleared lysates with RTT105 antibodies pre-bound to protein A/G beads for 2-4 hours at 4°C. Alternatively, use IgG sepharose beads for TAP-tagged constructs .

• Washing conditions: Wash beads 3-5 times with TMG-140 buffer to maintain specific interactions while removing background.

• Elution: Elute with Laemmli buffer for direct analysis or use mild elution for maintaining native complexes.

• Detection: Analyze by western blotting with antibodies against RTT105 and its interacting partners (RPA subunits and Kap95) .

How can researchers troubleshoot weak or non-specific RTT105 antibody signals?

When troubleshooting RTT105 antibody signals:

• Antibody concentration optimization: Titrate antibody concentrations to determine optimal working dilutions for each application.

• Blocking optimization: Test different blocking agents (BSA, milk, commercial blockers) to reduce background.

• Sample enrichment: For low-abundance detection, consider using TAP-tagged RTT105 constructs or concentrate samples before analysis .

• Cross-reactivity assessment: Test antibody against extracts from rtt105Δ strains to identify any cross-reactive bands.

• Signal enhancement techniques: For weak signals, consider using signal amplification methods like tyramide signal amplification for immunofluorescence or enhanced chemiluminescence substrates for western blotting.

• Epitope masking: If interaction with RPA or other proteins masks the antibody epitope, consider mild denaturation methods or using antibodies targeting different RTT105 regions.

What is the best methodology for studying dynamic RTT105-RPA interactions?

To study the dynamic nature of RTT105-RPA interactions:

• Stopped-flow FRET analysis: Use RTT105 antibodies to validate fluorescently labeled RTT105 constructs used in FRET studies examining binding kinetics with RPA .

• Real-time immunoprecipitation: Perform time-course experiments with RTT105 antibodies to capture temporal changes in protein interactions.

• Live-cell imaging: Use cell-permeable fluorescent RTT105 antibody fragments to track dynamics in living cells.

• ChIP-seq time course: Apply RTT105 antibodies in time-resolved ChIP-seq to track association with DNA during replication.

• In vitro reconstitution assays: Use antibodies to validate purified components in biochemical reconstitution of RTT105-RPA loading onto ssDNA.

Studies showed that when ssDNA is available, RTT105 promotes formation of high-density RPA nucleoprotein filaments and then dissociates . Antibodies can help track this dynamic process both in vitro and in vivo.

How can RTT105 antibody studies in yeast inform human DNA replication research?

While RTT105 is a yeast protein, insights from antibody-based studies have broader implications:

• Comparative analysis: Develop antibodies against potential human functional homologs based on RTT105's role as an RPA chaperone.

• Conservation assessment: Use RTT105 antibodies in cross-species immunoprecipitation experiments to identify functionally related proteins in other organisms.

• Heterologous expression studies: Express RTT105 in human cell lines and use antibodies to study interactions with human RPA.

• Model system validation: Use RTT105 antibodies to validate yeast as a model for studying general mechanisms of RPA loading that might be conserved.

• Cancer research applications: Since replication stress is a hallmark of cancer cells, mechanistic insights from RTT105-RPA studies in yeast could inform cancer research focusing on RPA regulation .

What methodological approaches can detect RTT105 in different genetic backgrounds?

For detecting RTT105 across different genetic contexts:

• Western blotting optimization: Adjust extraction methods and antibody conditions for different yeast strains (W303, S288C, DBY747, BY4742) .

• Growth condition considerations: RTT105's role becomes more critical under replication stress, so detection protocols may need adjustment based on growth conditions .

• Antibody validation in mutant strains: Validate antibody performance in strains with RPA mutations (zm1, zm2, t33) which maintain interaction with RTT105 but have altered DNA functions .

• Synthetic genetic interactions: When studying RTT105 in strains with additional mutations (like rtt101Δ), consider how genetic interactions might affect protein expression and antibody detection .

• Temperature considerations: Optimize detection protocols for different temperatures, as rtt105Δ cells show temperature-sensitive phenotypes (especially at 16°C) .